Stay updated on Daratumumab in AL Amyloidosis Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in AL Amyloidosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in AL Amyloidosis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record for the completed Phase 3 AL amyloidosis trial is displayed, including its treatment arms, eligibility criteria, outcomes, locations, publications, and study documents.
    Difference
    100%
    Check dated 2026-11-11T02:08:14.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-04T00:41:10.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    An NIH site-transition announcement banner appears above the 403 error page, and the footer revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:43:11.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:51:20.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, replacing the usual study record content. This indicates an access/server issue rather than changes to the study data.
    Difference
    18%
    Check dated 2026-09-23T00:45:30.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing Revision: v3.6.6. This reflects an update to the page's revision metadata rather than substantive changes to the study data or content.
    Difference
    0.0%
    Check dated 2026-09-16T00:09:17.000Z thumbnail image

Stay in the know with updates to Daratumumab in AL Amyloidosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in AL Amyloidosis Clinical Trial page.